Vilket är priset för DelMar Pharmaceuticals, Inc. (DMPWW)

Priset för DelMar Pharmaceuticals, Inc. (DMPWW) är $0.005

Vilket är marknadsvärdet för DelMar Pharmaceuticals, Inc. (DMPWW)

Marknadsvärdet för DelMar Pharmaceuticals, Inc. (DMPWW) är $1.74K

DelMar Pharmaceuticals, Inc. (DMPWW) Pris och Marknadsvärde

Kintara Therapeutics, Inc., previously known as DelMar Pharmaceuticals, Inc. until its rebranding in August 2020, operates as a clinical-stage pharmaceutical firm. Headquartered in San Diego, California, and established in 2009, the company is committed to advancing and bringing to market anti-cancer treatments for patients. Its development pipeline includes two advanced therapeutic candidates. One is VAL-083, a DNA-targeting agent poised for Phase III trials, designed to combat various drug-resistant solid tumors such as glioblastoma multiforme, ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma. The other is REM-001, a late-stage photodynamic therapy intended for conditions like cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and addressing access graft failure in hemodialysis patients. Kintara Therapeutics also maintains a strategic alliance with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. for the manufacturing and commercialization of VAL-083 within the Chinese market.

Pris för DMPWW	Tillgång B	Marknadsvärdet för B	Resultat
$15,477,429 $1.74K	NVDA	$5.383T	+309,548,585,950.26%
$12,717,472 $1.74K	AAPL	$4.423T	+254,349,445,230.23%
$11,961,271 $1.74K	GOOG	$4.160T	+239,225,426,792.19%
$10,532,232 $1.74K	MSFT	$3.663T	+210,644,634,308.60%
$8,312,428 $1.74K	AMZN	$2.891T	+166,248,564,985.39%

Pris för DMPWW

Tillgång B

Marknadsvärdet för B

Resultat

$15,477,429 $1.74K